Lyka Labs Limited (LYKALABS.NS)

INR 110.34

(-0.31%)

Total Liabilities Summary of Lyka Labs Limited

Lyka Labs Limited's latest annual total liabilities in 2023 was 884.58 Million INR , down -16.43% from previous year.
Lyka Labs Limited's latest quarterly total liabilities in 2024 Q1 was -682.65 Million INR , down -177.17% from previous quarter.
Lyka Labs Limited reported annual total liabilities of 1.05 Billion INR in 2022, down -38.5% from previous year.
Lyka Labs Limited reported annual total liabilities of 1.72 Billion INR in 2021, down -19.98% from previous year.
Lyka Labs Limited reported quarterly total liabilities of 836.14 Million INR for 2023 Q2, down 0.0% from previous quarter.
Lyka Labs Limited reported quarterly total liabilities of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Liabilities Chart of Lyka Labs Limited (2023 - 2009)

Historical Annual Total Liabilities of Lyka Labs Limited (2023 - 2009)

Year	Total Liabilities	Total Liabilities Growth
2023	884.58 Million INR	-16.43%
2022	1.05 Billion INR	-38.5%
2021	1.72 Billion INR	-19.98%
2020	2.15 Billion INR	0.09%
2019	2.14 Billion INR	25.22%
2018	1.71 Billion INR	-2.96%
2017	1.76 Billion INR	-14.29%
2016	2.06 Billion INR	7.21%
2015	1.92 Billion INR	-17.11%
2014	2.32 Billion INR	-15.03%
2013	2.73 Billion INR	24.69%
2012	2.19 Billion INR	3.53%
2011	2.11 Billion INR	-0.77%
2010	2.13 Billion INR	19.17%
2009	1.78 Billion INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	-682.65 Million INR	-177.17%
2023 Q2	836.14 Million INR	0.0%
2023 Q1	- INR	-100.0%
2023 FY	884.58 Million INR	-16.43%
2023 Q4	884.58 Million INR	0.0%
2023 Q3	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q2	1.68 Billion INR	0.0%
2022 Q1	- INR	-100.0%
2022 FY	1.05 Billion INR	-38.5%
2022 Q4	1.05 Billion INR	0.0%
2021 FY	1.72 Billion INR	-19.98%
2021 Q2	1.75 Billion INR	0.0%
2021 Q3	- INR	-100.0%
2021 Q1	- INR	-100.0%
2021 Q4	1.72 Billion INR	0.0%
2020 Q4	2.15 Billion INR	0.0%
2020 Q3	- INR	-100.0%
2020 Q2	2.18 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 FY	2.15 Billion INR	0.09%
2019 Q4	2.14 Billion INR	0.0%
2019 FY	2.14 Billion INR	25.22%
2019 Q3	- INR	-100.0%
2019 Q2	1.76 Billion INR	0.0%
2019 Q1	- INR	-100.0%
2018 Q1	- INR	0.0%
2018 FY	1.71 Billion INR	-2.96%
2018 Q4	1.71 Billion INR	0.0%
2017 FY	1.76 Billion INR	-14.29%
2016 Q4	2.06 Billion INR	0.0%
2016 Q1	- INR	-100.0%
2016 Q2	2.09 Billion INR	0.0%
2016 FY	2.06 Billion INR	7.21%
2016 Q3	- INR	-100.0%
2015 FY	1.92 Billion INR	-17.11%
2015 Q2	1.87 Billion INR	0.0%
2015 Q4	1.92 Billion INR	2.4%
2015 Q1	- INR	-100.0%
2015 Q3	1.87 Billion INR	0.0%
2014 Q4	2.32 Billion INR	0.0%
2014 Q1	3.03 Billion INR	0.0%
2014 FY	2.32 Billion INR	-15.03%
2013 Q3	- INR	-100.0%
2013 Q1	2.19 Billion INR	0.0%
2013 FY	2.73 Billion INR	24.69%
2013 Q2	2.12 Billion INR	-2.86%
2012 Q4	2.19 Billion INR	0.0%
2012 FY	2.19 Billion INR	3.53%
2012 Q3	- INR	-100.0%
2012 Q2	2.15 Billion INR	0.0%
2011 FY	2.11 Billion INR	-0.77%
2010 FY	2.13 Billion INR	19.17%
2009 FY	1.78 Billion INR	0.0%

Peer Total Liabilities Comparison of Lyka Labs Limited

Name	Total Liabilities	Total Liabilities Difference
Biocon Limited	307.95 Billion INR	99.713%
Blue Jet Healthcare Limited	2.13 Billion INR	58.591%
Concord Biotech Limited	1.74 Billion INR	49.18%
Dishman Carbogen Amcis Limited	39.53 Billion INR	97.763%
Jubilant Ingrevia Limited	19.94 Billion INR	95.565%
Panacea Biotec Limited	4.02 Billion INR	77.996%
Piramal Pharma Limited	74 Billion INR	98.805%
SMS Lifesciences India Limited	1.96 Billion INR	55.07%
Supriya Lifescience Limited	1.05 Billion INR	16.446%
Syngene International Limited	18.93 Billion INR	95.329%
TAKE Solutions Limited	969.78 Million INR	8.785%
Zota Health Care Limited	1.38 Billion INR	36.063%